GlassScriptPhysician profile
Heather R Shah
NPI 1093767493
$17,121.54
in general payments reported to CMS, 2019-2025
77 companies · $3,492 in 2025
The $3,492 reported for 2025 was more than what 77% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,296 · 2020: $1,079 · 2021: $357 · 2022: $2,333 · 2023: $2,715 · 2024: $3,849 · 2025: $3,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,732 · Grant: $501 · Education: $403 · Consulting Fee: $300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,732.47 |
| Grant | $500.50 |
| Education | $402.84 |
| Consulting Fee | $300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $120.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,223.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,167.98 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $971.78 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $964.24 | 2019-2025 | Imfinzi, Lynparza, Calquence |
| Janssen Biotech, INC. | $915.53 | 2019-2025 | Rybrevant, Darzalex, Talvey |
| Abbvie INC. | $873.58 | 2019-2025 | Venclexta |
| E.R. Squibb & Sons, L.L.C. | $791.03 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Seagen INC. | $752.57 | 2019-2024 | Tukysa, Padcev, Adcetris |
| Amgen INC. | $612.33 | 2019-2023 | Kyprolis, Blincyto, Nplate |
| Genzyme Corporation | $607.06 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $532.85 | 2019-2025 | Voydeya, Ultomiris, Soliris |
| Genentech USA, INC. | $453.57 | 2019-2025 | Venclexta, Polivy, Tecentriq |
| Gilead Sciences, INC. | $438.86 | 2019-2025 | Trodelvy |
| Incyte Corporation | $409.12 | 2019-2025 | Jakafi |
| Astellas Pharma US INC | $392.57 | 2019-2025 | Xtandi, Vyloy |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $359.45 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $356.85 | 2022-2025 | Ninlaro, Alunbrig, Iclusig |
| Bayer Healthcare Pharmaceuticals INC. | $348.13 | 2019-2025 | |
| Celgene Corporation | $316.75 | 2020-2025 | Reblozyl, Opdualag |
| Daiichi Sankyo INC. | $233.89 | 2019-2025 | Enhertu, Datroway |
| Pharmacyclics LLC, An Abbvie Company | $229.17 | 2019-2023 | Imbruvica |
| Eisai INC. | $211.30 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $201.90 | 2019-2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.08 | 2019-2025 | Gilotrif |
| Beigene USA, INC. | $173.46 | 2022-2025 | Brukinsa, Tevimbra |
| Exelixis INC. | $172.30 | 2019-2025 | Cabometyx |
| Beone Medicines USA, INC. | $165.50 | 2025 | Brukinsa, Tevimbra |
| Stemline Therapeutics INC. | $157.11 | 2023-2025 | Orserdu |
| Glaxosmithkline, LLC. | $146.39 | 2022-2024 | Ojjaara, Jemperli, Zejula |
| Tersera Therapeutics LLC | $144.19 | 2019-2025 | Xermelo, Zoladex |
| Servier Pharmaceuticals LLC | $131.87 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $113.53 | 2019-2024 | Somatuline Depot, Onivyde |
| Agios Pharmaceuticals, INC. | $110.38 | 2022-2025 | Pyrukynd |
| Deciphera Pharmaceuticals INC. | $104.78 | 2022-2025 | Qinlock, Romvimza |
| Blueprint Medicines Corporation | $100.48 | 2022-2024 | Ayvakit |
| Puma Biotechnology, INC. | $100.34 | 2019-2025 | |
| Array Biopharma INC | $99.14 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Aveo Pharmaceuticals, INC. | $97.64 | 2022-2025 | Fotivda |
| Kite Pharma, INC. | $92.31 | 2020-2025 | Yescarta |
| Sobi, INC | $89.16 | 2022-2025 | |
| Genmab U.S., INC. | $73.36 | 2023-2025 | Epkinly |
| Emd Serono, INC. | $73.03 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $71.03 | 2019-2022 | |
| Coherus Oncology, INC. | $67.72 | 2022-2024 | |
| Mirati Therapeutics, INC. | $66.94 | 2023 | Krazati |
| Acrotech Biopharma INC. | $66.54 | 2022-2023 | Beleodaq |
| Adc Therapeutics America, INC. | $64.73 | 2022-2025 | |
| Pharmaessentia USA Corporation | $61.85 | 2023-2025 | Besremi |
| Adaptive Biotechnologies Corporation | $59.65 | 2023-2025 | Clonoseq |
| Springworks Therapeutics, INC. | $59.27 | 2024-2025 | Ogsiveo |
| Janssen Pharmaceuticals, INC | $57.18 | 2019 | |
| Biocompatibles, INC. | $56.69 | 2019 | |
| Sumitomo Pharma America, INC. | $56.62 | 2023-2024 | Orgovyx |
| Clovis Oncology, INC. | $53.43 | 2019-2020 | |
| Immunogen, INC. | $50.28 | 2023 | Elahere |
| Pharmacosmos Therapeutics INC. | $48.06 | 2022-2023 | Monoferric |
| Tesaro, INC. | $44.17 | 2019 | |
| Dova Pharmaceuticals | $44.04 | 2019-2020 | |
| Rigel Pharmaceuticals, INC. | $43.36 | 2022-2024 | Tavalisse, Rezlidhia |
| Myovant Sciences INC. | $42.86 | 2022 | |
| Recordati_rare_diseases_inc. | $42.04 | 2025 | Enjaymo |
| Kyowa Kirin, INC. | $41.60 | 2019-2025 | |
| Eusa Pharma (US) LLC | $34.14 | 2019-2022 | |
| Global Blood Therapeutics, INC. | $33.06 | 2020-2022 | |
| Janssen Scientific Affairs, LLC | $30.50 | 2023 | Darzalex, Tecvayli |
| Secura Bio, INC. | $26.66 | 2019 | |
| Beckman Coulter, INC. | $24.15 | 2021 | |
| Iovance Biotherapeutics, INC. | $23.48 | 2025 | Amtagvi |
| Shire North American Group INC | $18.78 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $18.65 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $17.65 | 2019 | |
| Morphosys, US INC. | $17.45 | 2022 | |
| Karyopharm Therapeutics INC. | $17.36 | 2023 | Xpovio |
| Mylan Institutional INC. | $14.25 | 2020 | |
| Foundation Medicine, INC. | $13.73 | 2023 | |
| Aurobindo Pharma USA, INC. | $11.80 | 2020 | |
| Epizyme, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.